Mark Gurney, Senior VP Drug Discovery & Dvpmt at DECODE GENETICS INC (DCGN), bought 1,000 shares at $3.28 ($3K) on 2007-06-05, disclosed to the SEC on 2007-06-05.
Open-market purchase of $3k DCGN by Senior VP Drug Discovery & Dvpmt. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.